The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease
Abstract
Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism has previously been implicated in Alzheimer's disease (AD)-related cognitive impairment. We aimed to determine the relationship between BDNF Val66Met and beta-amyloid (Aβ) on cognitive decline, hippocampal atrophy, and Aβ accumulation over 36 months in 165 healthy adults enrolled in the Australian Imaging, Biomarkers and Lifestyle study. In healthy adults with high Aβ, Met carriers showed significant and moderate-to-large declines in episodic memory, executive function, and language, and greater hippocampal atrophy over 36 months, compared with Val/Val homozygotes. BDNF Val66Met was not found to be related to rates of change in cognition or hippocampal volume in healthy adults with low Aβ. BDNF Val66Met did not relate to the amount of Aβ or to the rate of Aβ accumulation in either group. High Aβ levels coupled with Met carriage may be useful prognostic markers of accelerated cognitive decline and hippocampal degeneration in individuals in the preclinical stage of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the study conducted in healthy adults having a high Aβ level and carrying the Met allele, the rate of HV reduction was significantly more.”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [72]
In the citing paper
“A greater reduction rate in HV was observed in Val/Val homozygotes who were having high Aβ levels than with low Aβ, irrespective of their BDNF Val66Met polymorphism over 36 months.”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [72]
In the citing paper
“The decline in memory with the reduction in hippocampal volume (HV) corresponding with high Aβ levels has been already reported in healthy individuals; Lim et al. (2013) showed that BDNF Val66Met worsens these conditions more in the preclinical stage of AD [72].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [72]
In the citing paper
“The decline in memory with the reduction in hippocampal volume (HV) corresponding with high Aβ levels has been already reported in healthy individuals; Lim et al. (2013) showed that BDNF Val66Met worsens these conditions more in the preclinical stage of AD [72].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [72]
Citations
Cites
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Self-citationExercise builds brain health: key roles of growth factor cascades and inflammation
Cotman, C. W., Berchtold, N. C., & Christie, L.-A. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.011 · Cited by 2,268
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857
Alzheimer’s Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W. J., Trojanowski, J. Q., Toga, A. W., & Beckett, L. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,493
Effects of Aerobic Exercise on Mild Cognitive Impairment: A Controlled Trial
Baker, L. D., Frank, L. L., Foster-Schubert, K., Green, P. S., Wilkinson, C. W., McTiernan, A., Plymate, S. R., Fishel, M. A., Watson, G. S., Cholerton, B. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.307 · Cited by 1,171
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., & Weinberger, D. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06690.2003 · Cited by 1,045
Ellis, K. A., Bush, A. I., Darby, D., Fazio, D. D., Foster, J. K., Hudson, P. J., Lautenschlager, N. T., Lenzo, N. P., Martins, R. N., Maruff, P. T., et al. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209009405 · Cited by 1,005
Self-citationAmyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986
Self-citationJack, C. R., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., Knopman, D. S., Boeve, B. F., Klunk, W. E., Mathis, C. A., et al. (2008) · Brain · doi:10.1093/brain/awm336 · Cited by 958
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
Villemagne, V. L., Pike, K. E., Chételat, G., Ellis, K. A., Mulligan, R. S., Bourgeat, P., Ackermann, U., Jones, G., Szoeke, C., Salvado, O., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22248 · Cited by 833
Self-citationPeng, S., Wuu, J., Mufson, E. J., & Fahnestock, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03135.x · Cited by 691
Brain-derived neurotrophic factor is reduced in Alzheimer's disease
Connor, B., Young, D., Yan, Q., Faull, R. L. M., Synek, B., & Dragunow, M. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00125-3 · Cited by 581
Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer DiseasePreprint
Masters, C. L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006262 · Cited by 554
Self-citationBDNF Val66Met Allele Is Associated with Reduced Hippocampal Volume in Healthy Subjects
Bueller, J. A., Aftab, M., Sen, S., Gomez‐Hassan, D. M., Burmeister, M., & Zubieta, J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.022 · Cited by 458
miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model
Lee, S., Chu, K., Jung, K., Kim, J. H., Huh, J., Yoon, H., Park, D., Lim, J., Kim, J., Jeon, D., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23588 · Cited by 326
Exercise counteracts declining hippocampal function in aging and Alzheimer's disease
Intlekofer, K. A., & Cotman, C. W. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.011 · Cited by 300
Villain, N., Chételat, G., Grassiot, B., Bourgeat, P., Jones, G., Ellis, K. A., Ames, D., Martins, R. N., Eustache, F., Salvado, O., et al. (2012) · Brain · doi:10.1093/brain/aws125 · Cited by 255
Self-citationCaccamo, A., Maldonado, M. A., Bokov, A. F., Majumder, S., & Oddo, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012851108 · Cited by 249
Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease
Ventriglia, M., Bocchio‐Chiavetto, L., Benussi, L., Binetti, G. G., Zanetti, O. O., Riva, M. A., & Gennarelli, M. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000952 · Cited by 240
Sperling, R. A., Aisen, P. S. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J. A., Montine, T. J., et al. (2011) · Cited by 197
Self-citationGarzon, D. J., & Fahnestock, M. L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5053-06.2007 · Cited by 182
Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition
Chételat, G., Villemagne, V. L., Villain, N., Jones, G. R., Ellis, K. A., Ames, D. J., Martins, R. N., Masters, C. L., & Rowe, C. C. (2012) · Neurology · doi:10.1212/wnl.0b013e318246d67a · Cited by 176
Self-citationHarris, S. E., Fox, H. C., Wright, A. F., Hayward, C., Starr, J. M., Whalley, L. J., & Deary, I. J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001799 · Cited by 173
Longitudinal change in cognitive performance among individuals with mild cognitive impairment.
Albert, M., Moss, M. B., Blacker, D., Tanzi, R., & McArdle, J. J. (2007) · Neuropsychology · doi:10.1037/0894-4105.21.2.158 · Cited by 160
Chételat, G., Villemagne, V. L., Pike, K. E., Ellis, K. A., Bourgeat, P., Jones, G. R., O'Keefe, G. J., Salvado, O., Szoeke, C. E. I., Martins, R. N., et al. (2011) · Brain · doi:10.1093/brain/awq383 · Cited by 159
Self-citationFukumoto, N., Fujii, T., Combarros, O., Kamboh, M. I., Tsai, S.-J., Matsushita, S., Nacmias, B., Comings, D. E., Arboleda, H., Ingelsson, M., et al. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30986 · Cited by 136
Voineskos, A. N., Lerch, J. P., Felsky, D., Shaikh, S. A., Rajji, T. K., Miranda, D., Lobaugh, N. J., Mulsant, B. H., Pollock, B. G., & Kennedy, J. L. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.194 · Cited by 131
Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults
Lim, Y. Y., Ellis, K. A., Pietrzak, R. H., Ames, D. J., Darby, D., Harrington, K., Martins, R. N., Masters, C. L., Rowe, C. C., Savage, G. R., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e9ae6 · Cited by 109
Self-citationBrain-derived neurotrophic factor gene polymorphisms and Alzheimer?s disease
Matsushita, S., Arai, H., Matsui, T., Yuzuriha, T., Urakami, K., Masaki, T., & Higuchi, S. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0210-3 · Cited by 93
Brain-Derived Neurotrophic Factor: the Link Between Amyloid-β and Memory Loss
Fahnestock, M. L. (2011) · Future Neurology · doi:10.2217/fnl.11.44 · Cited by 57
Dennis, N. A., Cabeza, R. E. L., Need, A. C., Waters, S., Goldstein, D. B., & LaBar, K. S. (2010) · Hippocampus · doi:10.1002/hipo.20809 · Cited by 48
BNDF modulates normal human hippocampal ageing
Sambataro, F., Murty, V. P., Lemaître, H., Reed, J. D., Das, S. R., Goldberg, T. E., Callicott, J. H., Weinberger, D. R., & Mattay, V. S. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.64 · Cited by 46
Nagata, T., Shinagawa, S., Nukariya, K., Yamada, H., & Nakayama, K. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000339358 · Cited by 37
The Biology of Alzheimer Disease
Landau, S. M., & Doraiswamy, P. M. (2012) · JAMA · doi:10.1001/jama.308.18.1925 · Cited by 30
Bicalho, M. A. C., Pimenta, F. A. P., Bastos‐Rodrigues, L., Hansen, É. D. O., Neves, S. C., Melo, M., Rosa, D. V., de Souza, R. P., de Miranda, D. M., de Moraes, E. N., et al. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3875 · Cited by 23
Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease
Xu, C., Wang, Z., Fan, M., Liu, B., Song, M., Zhen, X., & Jiang, T. (2010) · Neuroreport · doi:10.1097/wnr.0b013e32833ccaf4 · Cited by 21
Cited by
Sorted by citations
Miranda, M., Morici, J. F., Zanoni, M. B., & Bekinschtein, P. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00363 · Cited by 1,416
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820
The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
Sperling, R., Mormino, E., & Johnson, K. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.038 · Cited by 725
Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Its Pharmaceutical Potential
Gao, L., Zhang, Y., Sterling, K., & Song, W. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00279-0 · Cited by 606
The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease
Amidfar, M., de Oliveira, J., Kucharska, E., Budni, J., & Kim, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118020 · Cited by 419
Metadata
- Authors
- Lim, Y. Y., Villemagne, V. L., Laws, S. M., Ames, D., Pietrzak, R. H., Ellis, K. A., Harrington, K. D., Bourgeat, P., Salvado, O., Darby, D., Snyder, P. J., Bush, A. I., Martins, R. N., Masters, C. L., Rowe, C. C., Nathan, P. J., & Maruff, P.
- Affiliations
- Mental Health Research Institute (AU)
- Edith Cowan University (AU)
- The University of Melbourne (AU)
- Yale University (US)
- Australian e-Health Research Centre (AU)
- Brown University (US)
- GlaxoSmithKline (United Kingdom) (GB)
- Corresponding author
- Lim, Yen Ying
- ORCID
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 34
- Issue
- 11
- Pages
- 2457-2464
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W1998751550
- Cited by
- 124
- References
- 40
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 3 · 2023: 7 · 2022: 7 · 2021: 10 · 2020: 16 · 2019: 12 · 2018: 17 · 2017: 12 · 2016: 11 · 2015: 6 · 2014: 13 · 2013: 2
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- Research Online (Edith Cowan University) (submittedVersion)
- Swinburne figshare (Swinburne University of Technology) (submittedVersion)
- Funders
- Australian Commonwealth Scientific Industrial and research Organization
- Edith Cowan University
- Mental Health Research institute (MHRI), Alzheimer's Australia
- National Ageing Research Institute
- Austin Health, CogState Ltd.
- Hollywood Private Hospital
- Sir Charles Gardner Hospital
- National Health and Medical Research Council
- Dementia Collaborative Research Centres
- Science and Industry Endowment Fund
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- BDNF Val66Met polymorphism, brain-derived neurotrophic factor, amyloid-beta, preclinical Alzheimer's disease, cognitive decline, hippocampal atrophy, episodic memory, executive function, language, amyloid accumulation, prognostic factors
- MeSH terms
- Aged, Alzheimer Disease, Aniline Compounds, Australia, Cognition Disorders, Female, Genotype, Hippocampus, Humans, Magnetic Resonance Imaging, Male, Methionine, Neuropsychological Tests, Psychiatric Status Rating Scales, Thiazoles, Valine, Amyloid beta-Peptides, Brain-Derived Neurotrophic Factor, Positron-Emission Tomography, Apolipoprotein E4, Memory, Episodic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
